» Articles » PMID: 23349446

High-risk Patients Following Hospitalisation for an Acute Exacerbation of COPD

Overview
Journal Eur Respir J
Specialty Pulmonary Medicine
Date 2013 Jan 26
PMID 23349446
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this study was to assess long-term mortality and predictive factors of death after hospital admission for acute exacerbation of chronic obstructive pulmonary disease (COPD). 1824 patients (23.2% female; mean age 70.3±11.3 years) consecutively admitted for acute exacerbation of COPD in the respiratory medicine departments of 68 general hospitals between October 2006 and June 2007 were prospectively enrolled in a follow-up cohort. Their vital status was documented between October 2010 and April 2011. Vital status was available for 1750 patients (95.9%), among whom 787 (45%) died during follow-up. Multivariate analysis found that age (60-80 years and ≥80 years versus <60 years, relative risk 2.99, 95% CI 2.31-3.89), lower body mass index (25-30 kg·m(-2) versus ≤20 kg·m(-2), relative risk 0.80, 95% CI 0.66-0.97), lung cancer (relative risk 2.08, 95% CI 1.43-3.01), cardiovascular comorbidity (relative risk 1.35, 95% CI 1.16-1.58), previous hospital admissions for acute exacerbation of COPD (four or more versus none, relative risk 1.91, 95% CI 1.44-2.53), use of accessory respiratory muscles (relative risk 1.19, 95% CI 1.01-1.40) or lower-limb oedema (relative risk 1.74, 95% CI (1.44-2.12)) at admission and treatment by long-term oxygen therapy at discharge (relative risk 2.09, 95% CI 1.79-2.45) were independent risk factors of death. Mortality rate during the 4 years following hospital admission for acute exacerbation of COPD was high (45%). Simple clinical information relating to respiratory and general status can help in identifying high-risk patients and targeting more intensive follow-up and care. Interestingly, cardiovascular comorbidities and past hospitalisations for acute exacerbation of COPD, but not forced expiratory volume in 1 s, independently predicted the risk of death.

Citing Articles

Early Identification of Exacerbations in Patients with Chronic Obstructive Pulmonary Disease (COPD).

Voulgareli I, Antonogiannaki E, Bartziokas K, Zaneli S, Bakakos P, Loukides S J Clin Med. 2025; 14(2).

PMID: 39860403 PMC: 11765565. DOI: 10.3390/jcm14020397.


The impact of body mass index on mortality in COPD: an updated dose-response meta-analysis.

Tenda E, Henrina J, Setiadharma A, Felix I, Yulianti M, Pitoyo C Eur Respir Rev. 2024; 33(174).

PMID: 39603663 PMC: 11600125. DOI: 10.1183/16000617.0261-2023.


Acupuncture as adjunctive therapy for patients with AECOPD: study protocol for a multicenter, randomized controlled trial.

Yang C, Sun M, Xu G, Luo Q, Huang L, Tian H Front Public Health. 2023; 11:1235672.

PMID: 37849714 PMC: 10578458. DOI: 10.3389/fpubh.2023.1235672.


Pulmonary Rehabilitation for Adults with Chronic Respiratory Disease: An Official American Thoracic Society Clinical Practice Guideline.

Rochester C, Alison J, Carlin B, Jenkins A, Cox N, Bauldoff G Am J Respir Crit Care Med. 2023; 208(4):e7-e26.

PMID: 37581410 PMC: 10449064. DOI: 10.1164/rccm.202306-1066ST.


Lung Mycobiota α-Diversity Is Linked to Severity in Critically Ill Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.

Enaud R, Sioniac P, Imbert S, Janvier P, Camino A, Bui H Microbiol Spectr. 2023; :e0506222.

PMID: 36976010 PMC: 10100765. DOI: 10.1128/spectrum.05062-22.